National News

June 14, 2013

Court ruling may open up breast cancer gene tests

A ruling by the Supreme Court that human genes can’t be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the risk of developing breast or ovarian cancer.

In a bit of a mixed message, the court unanimously decided that certain types of gene tests may still be protected by patents, yet it struck down patents that a company has long held for BRCA genes. The company makes the only test for two of those breast cancer genes, BRCA1 and BRCA2.

“It appears that it will allow the market to open up so that other laboratories can offer the test,” said Rebecca Nagy, a genetics counselor at Ohio State University and president of the National Society of Genetic Counselors. And that should make the tests cheaper and available to more women, she said.

Hours after the ruling, one company — DNATraits, part of Houston-based Gene By Gene, Ltd. — said it would offer BRCA gene testing in the United States for $995 — less than a third of the current price.

A primer on the case:

Q: What did the court say?

A: Patents held by Myriad Genetics Inc. on BRCA1 and BRCA2 genes are not valid, because isolating a naturally occurring segment of DNA cannot be patented. We all have two copies of these genes; mutations in one of them can give a woman up to an 87 percent risk of developing breast cancer and up to a 54 percent risk for ovarian cancer.    

Q: How many people have them?

A: In the U.S., about 5 to 10 percent of breast cancers are thought to be due to bad BRCA genes. Among breast cancer patients, BRCA mutations are carried by 5 percent of whites and 12 percent of Eastern European (Ashkenazi) Jews. Rates in other groups aren’t as well known, but a recent study suggests they are more common than has been believed in blacks.   

Q: How expensive are the Myriad tests?

A: They cost $3,000 to $4,000 and insurers only cover them for women thought to be at high risk because of family history of breast or ovarian cancer or other risk factors. The tests are not recommended for women at average risk.

Q: What about other tests for breast cancer genes?

A: Some other tests look for mutations in 16 other genes less commonly involved in breast cancer but those have not been able to include BRCA1 and BRCA2 because of Myriad’s patents. Those other tests cost around $2,600. The court’s ruling means these tests likely will be able to include BRCA1 and BRCA2 for no or little additional cost in the future, giving a more complete picture of a woman’s risk, Nagy said.

Q: What about other gene tests that can still be patented?

A: The court said tests that involve making cDNA, or complementary DNA, can still be patented. They take an extra step to isolate only the “working parts” or coding regions of a gene.

———

Online:

Court decision: http://www.supremecourt.gov/opinions/12pdf/12-398—8njq.pdf.

———

Marilynn Marchione can be followed at http://twitter.com/MMarchioneAP

 

1
Text Only
National News
  • Police: Suspected killers wore GPS devices

    Two convicted sex offenders dutifully checked in with police every month and wore their GPS trackers around the clock — the rules of parole that are designed to tip off authorities if a freed felon backslides.

    April 15, 2014

  • Questions linger year after Boston Marathon bombs

    A surveillance video shows a man prosecutors say is Dzhokhar Tsarnaev placing a bomb near the finish line of the Boston Marathon, just yards from where an 8-year-old boy was killed when it exploded.

    April 15, 2014

  • 10 Things to Know for Tuesday

    Your daily look at late-breaking news, upcoming events and the stories that will be talked about Tuesday:

    April 15, 2014

  • Aw, geez, 'Fargo' is on TV with Billy Bob Thornton

    After failed attempts and broken dreams, by golly, someone went and put “Fargo” on series TV.

    April 15, 2014

  • Little sign of progress as Obama, Putin speak

    Speaking for the first time in more than two weeks, President Barack Obama and Russian President Vladimir Putin showed little sign of agreement Monday, with the U.S. leader urging pro-Russian forces to de-escalate the situation in eastern Ukraine and Putin denying that Moscow was interfering in the region.

    April 14, 2014

  • Drivers in California crash had clean records

    Both drivers in the fiery Northern California crash involving a FedEx truck and bus full of students had clean driving records.

    April 14, 2014

  • Post, Guardian win Pulitzers for NSA revelations

    The Washington Post and The Guardian won the Pulitzer Prize in public service Monday for revealing the U.S. government’s sweeping surveillance programs in a blockbuster series of stories based on secret documents supplied by NSA leaker Edward Snowden.

    April 14, 2014

  • Police: Utah mom admitted to killing her 6 babies

    Authorities say a Utah woman accused of killing six babies that she gave birth to over 10 years told investigators that she either strangled or suffocated the children and then put them inside boxes in her garage.

    April 14, 2014 1 Story

  • Deal signs bill extending tax-free holiday weekends

    Gov. Nathan Deal today signed House Bill 958, legislation that will extend the statewide back-to-school tax-free holiday and ENERGY STAR and WaterSense appliance tax-free holiday weekends for an additional two years.

    April 14, 2014

  • Chances of getting audited by IRS lowest in years

    As millions of Americans race to meet Tuesday’s tax deadline, their chances of getting audited are lower than they have been in years.

    April 14, 2014